Abstract
The accumulation of (+)- and (-)-propranolol was investigated in nine subjects who received 160 mg of racemic propranolol as a single dose and then once daily for 7 days. The serum concentrations of propranolol enantiomers were measured by h.p.l.c. using a novel chiral stationary phase allowing direct resolution of underivatized propranolol. The (+)-propranolol AUC increased from 412 +/- 223 ng ml-1 h after single doses (0-infinity) to 584 +/- 279 ng ml-1 h at steady-state (0-24 h) (P less than 0.05). Similarly, (-)-propranolol AUC increased from 609 +/- 304 to 777 +/- 370 ng ml-1 h (P less than 0.05). The AUC ratio (-)/(+) was 1.52 +/- 0.36 and 1.32 +/- 0.17 after single doses and steady-state, respectively (P greater than 0.05). Therefore, nonlinear accumulation occurs with both enantiomers although there is a trend for the (-)/(+) ratio to decrease at steady-state.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ariëns E. J. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol. 1984;26(6):663–668. doi: 10.1007/BF00541922. [DOI] [PubMed] [Google Scholar]
- Bai S. A., Wilson M. J., Walle U. K., Walle T. Stereoselective increase in propranolol bioavailability during chronic dosing in the dog. J Pharmacol Exp Ther. 1983 Nov;227(2):360–364. [PubMed] [Google Scholar]
- Silber B., Holford N. H., Riegelman S. Stereoselective disposition and glucuronidation of propranolol in humans. J Pharm Sci. 1982 Jun;71(6):699–704. doi: 10.1002/jps.2600710623. [DOI] [PubMed] [Google Scholar]
- Straka R. J., Lalonde R. L., Pieper J. A., Bottorff M. B., Mirvis D. M. Nonlinear pharmacokinetics of unbound propranolol after oral administration. J Pharm Sci. 1987 Jul;76(7):521–524. doi: 10.1002/jps.2600760706. [DOI] [PubMed] [Google Scholar]
- Straka R. J., Lalonde R. L., Wainer I. W. Measurement of underivatized propranolol enantiomers in serum using a cellulose-tris(3,5-dimethylphenylcarbamate) high-performance liquid chromatographic (HPLC) chiral stationary phase. Pharm Res. 1988 Mar;5(3):187–189. doi: 10.1023/a:1015921124857. [DOI] [PubMed] [Google Scholar]
- Wood A. J., Carr K., Vestal R. E., Belcher S., Wilkinson G. R., Shand D. G. Direct measurement of propranolol bioavailability during accumulation to steady-state. Br J Clin Pharmacol. 1978 Oct;6(4):345–350. doi: 10.1111/j.1365-2125.1978.tb00862.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- von Bahr C., Hermansson J., Lind M. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity. J Pharmacol Exp Ther. 1982 Aug;222(2):458–462. [PubMed] [Google Scholar]